It’s been a hodlers delight this week. The moment we’ve all been waiting for since probably mid-May when we started to see our fortunes plummet. If you’ve been paying…
October 21, 2021
Skyharbour is a company we watch closely here at Equity Guru. While we wait on news from the big show—additional drill results from the Company’s flagship Moore Uranium Project…
Bee Vectoring Technologies (BEE.C) is a company that is familiar to my weekly agriculture and ag tech readers. In the past weeks, I have been following the technicals as…
The computer security freight train that is Plurilock (PLUR.V) just keeps rolling, both in share price accretion, new contracts signed, and acquisitions. The latest of the latter comes in…
I have a bit of a sweet tooth. When I was little, my dad used to buy me those massive 64-ounce Jelly Belly containers from Costco. Even that wasn’t…
Aequus Pharmaceuticals(“AQS”) a specialty pharmaceutical company that develops and focuses on commercializing value-added products in specialty therapeutic areas in the Canadian market is today EG idea of the day….
This episode is all about Aequus Pharmaceuticals Inc. (AQS.V), a specialty pharmaceutical company, develops and commercializes drugs in Canada. It focuses on various therapeutic areas, including neurology, ophthalmology, and…
Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public…
Aequus Pharmaceuticals (AQS.V) is a growing specialty pharmaceutical company focused on developing and commercializing high quality, differentiated products. Aequus has grown its sales and marketing efforts to include several commercial…